Takeda Pharmaceutical (TAK) Earnings (2009 - 2026)
Takeda Pharmaceutical (TAK) earnings from Dec 31, 2009 to Mar 31, 2026. The TTM Takeda Pharmaceutical (TAK) earnings is $1.30B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Takeda Pharmaceutical (TAK) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +86.71% |
| 3 Years TTM | -17.85% |
| 5 Years TTM | -17.86% |
| 10 Years TTM | +7.26% |
| All Time TTM | -5.29% |
Annual Earnings change of Takeda Pharmaceutical (TAK)
| Year | Earnings | Change |
|---|---|---|
| 2026 | $1.28B | +77.94% |
| 2025 | $720M | -24.40% |
| 2024 | $952M | -60.11% |
| 2023 | $2.39B | +26.23% |
| 2022 | $1.89B | -44.30% |
| 2021 | $3.40B | +727.01% |
| 2020 | $411M | -58.24% |
| 2019 | $983M | -44.09% |
| 2018 | $1.76B | +70.38% |
| 2017 | $1.03B | +44.83% |
| 2016 | $713M | -158.69% |
| 2015 | -$1.21B | -217.49% |
| 2014 | $1.03B | -26.61% |
| 2013 | $1.41B | -6.88% |
| 2012 | $1.51B | -49.24% |
| 2011 | $2.98B | -6.48% |
| 2010 | $3.19B | +326.32% |
| 2009 | $747M | N/A |
Comparison Takeda Pharmaceutical (TAK) five years earnings CAGR with competitors
Takeda Pharmaceutical (TAK) five years earnings CAGR is -17.86%.